entertainment -WSS

entertainment

author：comprehensive 2025-10-02 08:49:06 - browse：6219

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Eli Lilly’s Mounjaro succeeds in second weight

leisure time

WSS

My daughter's legacy lives on through her writing, phage therapy

Statins may not be needed by millions of people, study suggests

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

New report analyzes digital physical therapy solutions' effectiveness

Biogen nominates mother of director’s child to replace him on board

NIH tests clinical research in primary care with $30 million program

focus

entertainment

explore

Jerome Adams on the need for new antivirals for Covid

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharma companies must ensure equitable access to obesity drugs

Continuity nursing helped my family in our darkest PICU moments

Biden administration plans revamp of organ transplant system

Tori Bowie and the unacceptable rates of Black maternal death

ALS patient reclaims some autonomy thanks to wearable 'robot'

Duchenne breakthrough therapy leaves behind pioneering families

Report captures long Covid’s disabling effects and policy challenges

focus

Coercive sterilizations revealed by STAT prompt outrage

Timeline: Key moments in fight for gay rights

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

'Essentially witchcraft:' A former naturopath takes on the field

Report captures long Covid’s disabling effects and policy challenges

Xenotransplantation trials will require adjusting expectations, experts say

focus

knowledge

leisure time

entertainment